cancer clinical trials in oklahoma
|
Cancer Centers of Southwest Oklahoma Research
Trial Locations Cancer Centers of Southwest Oklahoma Research Cancer Care Associates-Norman University of Oklahoma Health Sciences Center Cancer Care Associates-Mercy Mercy Physicians of Oklahoma-Lakeside Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
|
Oklahoma University Cancer Institute
Trial Locations Oklahoma University Cancer Institute Cancer Care Associates - Saint Francis Campus Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
|
GSK Investigational Site
Oklahoma City, Oklahoma 73112 Carcinoma, Renal Cell
|
|
ImClone Investigational Site
Oklahoma City, Oklahoma 73118 Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
|
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Solid Tumor
|
|
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Cancer Care Associates-Yale Recurrent Endometrial Carcinoma
|
|
Cancer Care Associates-Yale
Tulsa, Oklahoma 74136-1929 Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma 74136 Pancreatic Cancer
|
|
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Natalie W Bryant Cancer Center Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
|
Cancer Care Associates-Yale
Tulsa, Oklahoma 74136-1929 Ovarian Stromal Cancer
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tulsa, Oklahoma 74136 Non-small Cell Lung Cancer
|
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Pfizer Investigational Site
Bartlesville, Oklahoma 74006 Advanced Breast Cancer, Breast Cancer
|
|
Cancer Centers of Southwest Oklahoma Research
Trial Locations Cancer Centers of Southwest Oklahoma Research Cancer Care Associates-Norman University of Oklahoma Health Sciences Center Cancer Care Associates-Mercy Mercy Physicians of Oklahoma-Lakeside Cancer Care Associates Natalie W Bryant Cancer Center Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
|
|
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Cancer Care Associates-Yale Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
|
Cancer Care Associates - Saint Francis Campus
Tulsa, Oklahoma 74136-1929 Endometrial Cancer, Fatigue, Neurotoxicity
|
|
Southwestern Regional Medical Center
Tulsa, Oklahoma 74133 Breast Cancer
|
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
|
|
Cancer Centers of SW OK
Trial Locations Cancer Centers of SW OK University of Oklahoma Health Science Center Mercy Physicians of Oklahoma Cancer Care Associates- Tulsa Metastatic Pancreatic Cancer
|
|
Research Site
Enid, Oklahoma Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma 74136 Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
|
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma 74136 Lung Cancer
|
|
Novartis Investigative Site
Tulsa, Oklahoma 74136 Breast Cancer
|
|
Integris Cancer Institute of OK
Oklahoma City, Oklahoma 73142 Malignant Melanoma
|
|
Cancer Centers of Southwest Oklahoma
Lawton, Oklahoma 73505 Breast Cancer
|
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Leukemia
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma 74136 Liver Cancer
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Trial Locations Natalie Warren Bryant Cancer Center at St. Francis Hospital LaFortune Cancer Center at St. John Medical Center Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
|
|
Oklahoma University Cancer Institute
Trial Locations Oklahoma University Cancer Institute Natalie Warren Bryant Cancer Center at St. Francis Hospital Leukemia, Lymphoma
|
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
|
|
Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma 74136 Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
|
|
Natalie W Bryant Cancer Center
Tulsa, Oklahoma 74136 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
|
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Cancer Care Associates-Yale Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
